Laboratório Gross

Laboratório Gross is a traditional Brazilian pharmaceutical company founded in 1926, specializing in the development and commercialization of branded generic medications and nutritional supplements. The company maintains a strong market presence in several therapeutic areas, including gastroenterology, pediatrics, gynecology, and cardiology. Its portfolio features well-established brands in the Brazilian market, most notably Digesan (bromopride) and Ad-til (vitamins A and D). In 2017, Laboratório Gross was acquired by Biolab Farmacêutica, integrating its operations into one of Brazil's largest pharmaceutical groups while maintaining its distinct brand identity and legacy of quality. The company continues to provide essential treatments for primary care and specialized medical needs across Brazil.